Treatment of Skin Cancer with a Selective Apoptotic-Inducing CuradermBEC5 Topical Cream Containing Solasodine Rhamnosides - International Journal of Clinical Medicine

IJCM > Vol.6 No.5, May 2015

Treatment of Skin Cancer with a Selective Apoptotic-Inducing Curaderm^BEC5 Topical Cream Containing Solasodine Rhamnosides ()

HTML XML

Download as PDF (Size: 437KB) PP. 326-333

DOI: 10.4236/ijcm.2015.65042 4,618 Downloads 7,663 Views Citations

Author(s)

Aruba Cham, Bill Cham

Affiliation(s)

Australasian Medical Research, Port Vila, Republic of Vanuatu.

ABSTRACT

Solasodine rhamnosides produced in plants as secondary metabolites, are safe and effective when treating a variety of cancers, including non-melanoma skin cancers. They are cytotoxic against multi-drug resistant tumor cells, stimulate lasting immunity against cancer, are not mutagenic and display anti-mutagenic properties. These antineoplastics, through cellular specific receptor-mediated actions, directly induce apoptosis by triggering extrinsic and intrinsic apoptotic pathways in cancer cells but not normal cells. CuradermBEC5 contains solasodine rhamnosides and is a topical formulation for the treatment of keratoses and non-melanoma skin cancers. The mode of action, together with the selectivity towards cancer cells, with CuradermBEC5 therapy, results in outstanding beneficial outcomes. This study shows graphically and pictorially that CuradermBEC5 seeks and destroys basal cell carcinoma whilst normal skin cells replace the dead cancer cells during therapy, emanating into impressive cosmetic end results. The clinical observations with CuradermBEC5 therapy reveal that initially the lesion size increases over four-fold due to the interaction of CuradermBEC5 with deeper and more lateral tumor cells, followed by a decrease in size, ultimately, resulting in complete elimination of the basal cell carcinoma.

KEYWORDS

Skin Cancer, BEC, Solamargine, Curaderm, Apoptosis, Solasodine Rhamnosides

Share and Cite:

Cham, A. and Cham, B. (2015) Treatment of Skin Cancer with a Selective Apoptotic-Inducing Curaderm^BEC5 Topical Cream Containing Solasodine Rhamnosides. International Journal of Clinical Medicine, 6, 326-333. doi: 10.4236/ijcm.2015.65042.

Journals Menu

Follow SCIRP

	+1 323-425-8868
	customer@scirp.org
	+86 18163351462(WhatsApp)
	1655362766

	Paper Publishing WeChat

Journals Menu

Home

About SCIRP

Service

Policies